Monthly Archives: February 2019
P076 USING DEEP LEARNING FOR AUTOMATED GRADING OF ENDOSCOPIC DISEASE SEVERITY IN ULCERATIVE COLITIS
Objectives: Endoscopic severity of ulcerative colitis predicts clinical outcomes, making it critical for assessing efficacy of new therapies. However, its use in routine practice is limited by availability of experienced and trained human reviewers. … Continue reading
P077 A NOVEL PREDICTIVE NOMOGRAM FOR EARLY ENDOSCOPIC RECURRENCE AFTER INTESTINAL RESECTION FOR CROHN’S DISEASE
Most patients with Crohn’s disease (CD) that undergo intestinal resection will subsequently experience disease recurrence. Endoscopic recurrence (ER) after intestinal resection for CD precedes the clinical recurrence, and its severity correlates with… Continue reading
P078 CAPSULE SCORING OF ULCERATIVE COLITIS (CSUC) IS USEFUL FOR MONITORING INACTIVE ULCERATIVE COLITIS
We reported a novel 1-day colon capsule endoscopy (CCE) regimen with high completion rate and good acceptability especially in clinically inactive cases and therefore suggested its potential utility as a non-invasive monitoring tool to evaluate mucosal… Continue reading
P079 CORRELATION BETWEEN PUCAI, ENDOSCOPY AND PATHOLOGY SCORES IN A MAJORITY HISPANIC UC PEDIATRIC POPULATION
The current gold standard for monitoring the severity and treatment of ulcerative colitis is a combination of endoscopy mucosal scores with concomitant pathology scores. The Pediatric Ulcerative Colitis Assessment Index (PUCAI) was developed as an easy… Continue reading
P080 DYSMENORRHEA IN WOMEN WITH ULCERATIVE COLITIS
Dysmenorrhea and ulcerative colitis (UC) are conditions that commonly affect women of reproductive age. Despite their similar symptoms, the relationship between the two is poorly understood. The aims of this study were to explore the relationships betw… Continue reading
P081 HISTOLOGIC HEALING RATES OF MEDICAL THERAPIES FOR ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Histologic remission is a potentially valuable means of assessing disease activity and treatment response in ulcerative colitis (UC). However, the efficacy of existing therapies to achieve this outcome is unclear. We performed a systematic review and m… Continue reading
P082 PREOPERATIVE ANTI-TNFS ARE ASSOCIATED WITH A SHORTER INTERVAL TO DE NOVO CROHN’S DISEASE AFTER ILEAL POUCH-ANAL ANASTOMOSIS FOR ULCERATIVE COLITIS
Anti-tumor necrosis factor (anti-TNF) agents are widely used in the treatment of moderate to severe ulcerative colitis (UC) since commercial approval in 1998. Many patients however ultimately require surgery with ileal pouch-anal anastomosis (IPAA). Co… Continue reading
P083 VALIDATION OF A NEW PHYSICIAN GLOBAL ASSESSMENT COLONOSCOPY SCORE (PGA-CS) FOR PEDIATRIC CROHN’S DISEASE
Mucosal healing is widely recognized as the gold standard for assessing Crohn’s disease (CD) activity. Existing indices for assessing mucosal healing such as the simple endoscopic score for CD (SES-CD) are cumbersome and not commonly used in practice… Continue reading
P084 AN EVALUATION OF THE CLINICAL COURSE AND UTILIZATION PATTERNS FOR ACUTE AND CHRONIC POUCH-RELATED CONDITIONS AMONG PATIENTS TREATED IN A MULTICENTER COHORT
The most common complication following a proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the development of pouchitis, however gaps exist in our understanding of the clinical course of pouch-related disorders. We used data from a cohort of … Continue reading
P085 ANORECTAL CANCER ASSOCIATED WITH CROHN’S DISEASE
Patients with Crohn’s disease (CD) have increased risk of developing colorectal cancer (CRC) compared with the background population. In our previous study, CRC associated with CD in Japan mostly arises in anorectal region, while colonic cancer is pr… Continue reading